Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
Titel:
Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
Auteur:
Borte, Michael Pac, Malgorzata Serban, Margit Gonzalez-Quevedo, Teresa Grimbacher, Bodo Jolles, Stephen Zenker, Othmar Neufang-Hueber, Jutta Belohradsky, Bernd